Related Experiment Video
Updated: Jun 8, 2026

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
Published on: July 6, 2015
Tea catechin EGCg suppresses the mgl gene associated with halitosis
1Department of Pediatric Dentistry, College of Dentistry, University of Illinois at Chicago, MC850, 801 S. Paulina Street, Room 469J, Chicago, IL 60612-7212, USA.
Abstract:
Epigallocatechin gallate (EGCg), the main antimicrobial tea catechin, has been reported to inhibit growth and virulence factors of oral pathogens in vitro. Although the mechanism is unclear, the potential of EGCg in reducing halitosis caused by volatile sulfur compounds (VSCs) has been suggested. This study tested the hypothesis that EGCg reduces VSCs by suppressing mgl, the gene encoding L-methionine-α-deamino-γ-mercaptomethane-lyase, responsible for methyl mercaptan (CH₃SH) production by oral anaerobes. In this study, the effect of EGCg on in vitro growth, CH₃SH production, and mgl gene expression in P. gingivalis W83 was investigated. EGCg inhibited growth of P. gingivalis W83 (MIC = 97.5 µg/mL) and was bactericidal (MBC = 187.5 µg/mL). At sub-MIC levels, EGCg inhibited CH₃SH production, and mgl mRNA and protein expression (p < 0.05). We conclude that EGCg may represent a natural and alternative agent to the antimicrobial chemicals currently available for halitosis control.
Related Concept Videos
The Oral Microbiota
GPCRs Regulate Adenylyl Cylase Activity
Two...
Cell Specific Gene Expression
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
